Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I
Summary
The Drug Enforcement Administration (DEA) is proposing to make five synthetic drugs—clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam—illegal by classifying them as Schedule I controlled substances. These drugs are designer versions of prescription anti-anxiety medications that have been sold online and in stores, and the DEA wants to ban them because they pose health risks and are being abused.
Key Points
- 1Five designer drugs that mimic prescription anxiety medications would become illegal nationwide if this rule is finalized
- 2These substances have been sold online and in retail settings as 'legal' alternatives to banned drugs, but the DEA says they are dangerous and widely abused
- 3The public has until August 26, 2025 to submit comments supporting or opposing this proposed ban
- 4If approved, manufacturing, selling, or possessing these drugs would become a federal crime with serious penalties
- 5This is a proposed rule, meaning the DEA is requesting feedback before making it official law
Key Dates
July 25, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
AI Comment Drafter
Describe your concern and we'll help you draft a substantive comment.
AI-generated draft. Always review and edit before submitting. Replace all [bracketed placeholders] with your specific details. Your comment should reflect your genuine views and experience.